National Bank Of Canada Relay Therapeutics, Inc. Transaction History

National Bank Of Canada

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	BUY	$8.24 - $12.97 $13,184 - $20,752	1,600 New	1,600 $13,000
Q4 2022 Jan 24, 2023	BUY	$14.16 - $24.02 $3,540 - $6,005	250 Added 50.0%	750 $0
Q3 2022 Oct 13, 2022	SELL	$18.07 - $31.37 $9,035 - $15,685	-500 Reduced 50.0%	500 $0
Q2 2022 Jul 28, 2022	BUY	$13.31 - $34.88 $13,310 - $34,880	1,000 New	1,000 $17,000

190

127M

4.2K

1.7K

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $1.07B
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

Stay updated on National Bank Of Canada with notifications on news.